2013-as idegen nyelvű publikációk

  • Kappelmayer J, Beke Debreceni I, Vida A, Antal-Szalmás P, Clemetson KJ, Nagy B Jr. Distinct effects of Re- and S-forms of LPS on modulating platelet activation. J Throm Haemos (2013) 11(4): 775-778
  • Antal-Szalmás P, Nagy B Jr, Debreceni IB, Kappelmayer J. Measurement of Soluble Biomarkers by Flow Cytometry. EJIFCC. 2013 Jan 16;23(4):135-42
  • Reményi G, Szász R, Debreceni IB, Szarvas M, Batár P, Nagy B Jr, Kappelmayer J, Udvardy M. Comparison of coated-platelet levels in patients with essential thrombocythemia with and without hydroxyurea treatment. Platelets (2013) 24(6): 486-492
  • Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Laszlo Lakatos P, Kappelmayer J, Antal-Szalmás P. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. J Hepat (2013) 59(3): 457-466
  • Oláh Zs, Szarvas M, Bereczky Zs, Kerenyi A, Kappelmayer J, Boda Z. Direct thrombin inhibitors and factor Xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant. Arch Pathol Lab Med, 2013;137(7):967-973.
  • Bagoly Z, Sarkady F, Magyar T, Kappelmayer J, Pongrácz E, Csiba L, Muszbek L. Comparison of a New P2Y12 Receptor 1 Specific Platelet Aggregation Test with 2 Other Laboratory Methods in Stroke Patients on Clopidogrel Monotherapy. PLOS one (2013) 8(7): e69417
  • Bhattoa HP, Onyeka U, Kalina E, Balogh A, Paragh G, Antal-Szalmas P, Kaplar M. Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study. Clin Rheuma (2013) Aug; 32(8): 1161-7
  • Bhattoa HP, Wamwaki J, Kalina E, Foldesi R, Balogh A, Antal-Szalmas P. Serum sclerostin levels in healthy men over 50 years of age. J Bone Min Metabol (2013) Sep; 31(5): 579-84
  • Palicz Z, Jenes A, Gáll T, Miszti-Blasius K, Kollár S, Kovács I, Emri M, Márián T, Leiter E, Pócsi I, Csősz E, Kalló G, Hegedűs C, Virág L, Csernoch L, Szentesi P. In vivo application of a small molecular weight antifungal protein of Penicillium chrysogenum (PAF). Toxic App Pharmacol (2013) May 15; 269(1): 8-16
  • Olah AV, Szabo GP, Varga J, Balogh L, Csabi G, Csakvary V, Erwa W, Balogh I. Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome. Eur J Pediat (2013) 172:(5) 623-630
  • Bedekovics J, Rejto L, Telek B, Kiss A, Hevessy Z, Ujfalusi A, Mehes G. Identification of NPMc+ acute myeloid leukemia in bone marrow smears. App Immhistchem Mol Morph (2013) 21:(1) 73-78
  • Olah Z, Szarvas M, Bereczky Z, Kerenyi A, Kappelmayer J, Boda Z. Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant. Arch Pathol (2013) 137:(7) 967-973
  • Kovacs B, Bereczky Z, Olah Z, Gindele R, Kerenyi A, Selmeczi A, Boda Z, Muszbek L. The Superiority of Anti-FXa Assay Over Anti-FIIa Assay in Detecting Heparin-Binding Site Antithrombin Deficiency. Ame J Clin Pathol (2013) 140:(5) 675-679
  • Timar O, Szekanecz Z, Kerekes G, Vegh J, Olah AV, Nagy G, Csiki Z, Danko K, Szamosi S, Nemeth A, Soltesz P, Szucs G. Rosuvastatin improves impaired endothelial function, lowers high sensitivity C-reactive protein, complement and immuncomplex production in patients with systemic sclerosis: a prospective case-series study. Arth Res Therapy (2013) 15:(5) R105
  • Gaál K, Lorincz H, Seres I, Harangi M, Oláh AV, Paragh G. Characterization of a novel high-density lipoprotein antioxidant capacity assay and its application to high-density lipoprotein fractions. Clin Biochem (2013) 46:(9) 825-827
  • Goldstein SR, Bhattoa HP, Neven P, Cox DA, Dowsett SA, Alam J, Sipos A, Muram D. Gynecological effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass. Menopause J N Am Menop Soc (2012) 19:(1) 41-47
  • Miszti-Blasius K, Felszeghy S, Kiss C, Benkő I, Géresi K, Megyeri A, Hevessy Z, Kappelmayer J. P-selectin glycoprotein ligand-1 deficiency augments G-CSF induced myeloid cell mobilization. Naun Schmied Arch Pharmacol (2014) Feb; 387(2):109-18
  • Bessenyei B, Nagy A, Balogh E, Novák L, Bognár I, Knegt AC, Oláh E Achondroplasia with multiple suture craniosynostosis: a report of a new case of this rare association. Am J Med Genet. (2013) Oct, 161A(10):2641-2644.
  • Kovács B, Bereczky Z, Oláh Z, Gindele R, Kerényi A, Selmeczi A, Boda Z, Muszbek L. The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency. Am J Clin Pathol. 2013 Nov;140(5):675-9.

Frissítés dátuma: 2019.06.27.